{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:50:33Z","timestamp":1791334233820,"version":"4.3.1"},"reference-count":46,"publisher":"BMJ","funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["unrestricted grant"],"award-info":[{"award-number":["unrestricted grant"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"accepted":{"date-parts":[[2026,9,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Retrospective cohort study using the TriNetX database to explore the relationship between statin use and glaucoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The open-angle glaucoma (OAG) incidence analysis consisted of individuals over 40 years of age with statin use and ophthalmological follow-up within 1 year prior. The OAG treatment analysis consisted of individuals with glaucoma and concurrent statin use. Outcomes included rates of OAG onset, topical ocular hypotensive prescription, incisional glaucoma surgery, minimally invasive glaucoma surgery (MIGS) and selective laser trabeculoplasty (SLT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>210\u2009701 matched patients were included in the OAG incidence analysis and 29\u2009598 in the OAG treatment analysis. At 5 years, statin use was associated with lower risk of OAG incidence (HR 0.85 (95% CI 0.82 to 0.89)), as well as treatment escalation to incisional glaucoma surgery (HR 0.64 (95% CI 0.58 to 0.71)), MIGS (HR 0.45 (95% CI 0.41 to 0.50)) or SLT (HR 0.40 (95% CI 0.36 to 0.44)) and lower rates of topical ocular hypotensive prescription (HR 0.89 (95% CI 0.86 to 0.91)). At 10 years, statin use was associated with lower risk of OAG incidence (HR 0.90 (95% CI 0.87 to 0.93)), escalation to incisional glaucoma surgery (HR 0.68 (95% CI 0.63 to 0.75)), MIGS (HR 0.54 (95% CI 0.49 to 0.59)) or SLT (HR 0.49 (95% CI 0.45 to 0.52)) and lower rates of topical ocular hypotensive prescription (HR 0.88 (95% CI 0.86 to 0.91)).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results suggest that statin use is associated with lower risk of glaucoma onset and treatment escalation. Prospective trials are needed to further elucidate the relationship between statin usage and glaucoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bjo-2026-330339","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:18Z","timestamp":1791331218000},"page":"bjo-2026-330339","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Statin use is associated with lower risk of open-angle glaucoma incidence and treatment escalation"],"prefix":"10.1136","author":[{"given":"Forest","family":"Lin","sequence":"first","affiliation":[{"name":"Morsani College of Medicine, University of South Florida, Tampa, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8689-6391","authenticated-orcid":false,"given":"Alexander T","family":"Hong","sequence":"additional","affiliation":[{"name":"Keck School of Medicine, University of Southern California, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9553-3202","authenticated-orcid":false,"given":"Robert N","family":"Weinreb","sequence":"additional","affiliation":[{"name":"Hamilton Glaucoma Center, Shiley Eye Institute and Department of Ophthalmology, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"2026100617000934000_bjo-2026-330339v1.1","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0140-6736(23)01289-8","article-title":"Glaucoma: now and beyond","volume":"402","author":"Jayaram","year":"2023","journal-title":"The Lancet"},{"key":"2026100617000934000_bjo-2026-330339v1.2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.120.6.701"},{"key":"2026100617000934000_bjo-2026-330339v1.3","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.120.10.1268"},{"key":"2026100617000934000_bjo-2026-330339v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(98)00223-2"},{"key":"2026100617000934000_bjo-2026-330339v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(98)00272-4"},{"key":"2026100617000934000_bjo-2026-330339v1.6","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10078-1383"},{"key":"2026100617000934000_bjo-2026-330339v1.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.optom.2016.02.003"},{"key":"2026100617000934000_bjo-2026-330339v1.8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2174\/1874364100903020038","article-title":"Risk factors for glaucoma needing more attention","volume":"3","author":"Coleman","year":"2009","journal-title":"Open Ophthalmol J"},{"key":"2026100617000934000_bjo-2026-330339v1.9","doi-asserted-by":"crossref","DOI":"10.1007\/s11892-016-0815-6","article-title":"Presence and risk factors for glaucoma in patients with diabetes","volume":"16","author":"Song","year":"2016","journal-title":"Curr Diab Rep"},{"key":"2026100617000934000_bjo-2026-330339v1.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2014.05.029"},{"key":"2026100617000934000_bjo-2026-330339v1.11","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/aos.14769","article-title":"Cholesterol and glaucoma: a systematic review and meta\u2010analysis","volume":"100","author":"Posch\u2010Pertl","year":"2022","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"2026100617000934000_bjo-2026-330339v1.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2004.08.003"},{"key":"2026100617000934000_bjo-2026-330339v1.13","first-page":"425","article-title":"Mechanical environment of the optic nerve head in glaucoma","volume":"85","author":"Downs","year":"2008","journal-title":"Ophthalmic Vis Sci"},{"key":"2026100617000934000_bjo-2026-330339v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100916"},{"key":"2026100617000934000_bjo-2026-330339v1.15","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/s41433-018-0050-2","article-title":"Neuroprotective agents in the management of glaucoma","volume":"32","author":"Nucci","year":"2018","journal-title":"Eye (Lond)"},{"key":"2026100617000934000_bjo-2026-330339v1.16","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.ophtha.2018.06.017","article-title":"Oral memantine for the treatment of glaucoma: design and results of 2 randomized, placebo-controlled, phase 3 studies","volume":"125","author":"Weinreb","year":"2018","journal-title":"Ophthalmology"},{"key":"2026100617000934000_bjo-2026-330339v1.17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ajo.2025.12.003","article-title":"Tirzepatide is associated with reduced risk of primary open-angle glaucoma and ocular hypertension in patients with type 2 diabetes","volume":"283","author":"Hong","year":"2026","journal-title":"Am J Ophthalmol"},{"key":"2026100617000934000_bjo-2026-330339v1.18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/JAD-2010-101179","article-title":"Statins as neuroprotectants: a comparative in vitro study of lipophilicity, blood-brain-barrier penetration, lowering of brain cholesterol, and decrease of neuron cell death","volume":"23","author":"Sierra","year":"2011","journal-title":"JAD"},{"key":"2026100617000934000_bjo-2026-330339v1.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2009.02.002"},{"key":"2026100617000934000_bjo-2026-330339v1.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.08.016"},{"key":"2026100617000934000_bjo-2026-330339v1.21","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1167\/iovs.19-27984","article-title":"Association of systemic medication exposure with glaucoma progression and glaucoma suspect conversion in the Groningen Longitudinal Glaucoma Study","volume":"60","author":"Pappelis","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2026100617000934000_bjo-2026-330339v1.22","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-18595"},{"key":"2026100617000934000_bjo-2026-330339v1.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.04.029"},{"key":"2026100617000934000_bjo-2026-330339v1.24","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2021-318789"},{"key":"2026100617000934000_bjo-2026-330339v1.25","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002018","article-title":"Association between statin use and open-angle glaucoma in hyperlipidemia patients","volume":"94","author":"Chen","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"2026100617000934000_bjo-2026-330339v1.26","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101364","article-title":"Associations of statin use with the onset and progression of open-angle glaucoma: a systematic review and meta-analysis","volume":"46","author":"Yuan","year":"2022","journal-title":"EClinicalMedicine"},{"key":"2026100617000934000_bjo-2026-330339v1.27","doi-asserted-by":"crossref","DOI":"10.1093\/jamiaopen\/ooad035","article-title":"A global federated real-world data and analytics platform for research","volume":"6","author":"Palchuk","year":"2023","journal-title":"JAMIA Open"},{"key":"2026100617000934000_bjo-2026-330339v1.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.11.008"},{"key":"2026100617000934000_bjo-2026-330339v1.29","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.122.6.822"},{"key":"2026100617000934000_bjo-2026-330339v1.30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029724","article-title":"Cholesterol-lowering drugs and incident open-angle glaucoma: a population-based cohort study","volume":"7","author":"Marcus","year":"2012","journal-title":"PLoS One"},{"key":"2026100617000934000_bjo-2026-330339v1.31","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.124.5.665"},{"key":"2026100617000934000_bjo-2026-330339v1.32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1001\/jamaophthalmol.2016.5406","article-title":"Association of daily dosage and type of statin agent with risk of open-angle glaucoma","volume":"135","author":"Talwar","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"2026100617000934000_bjo-2026-330339v1.33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2007.01529.x"},{"key":"2026100617000934000_bjo-2026-330339v1.34","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1490"},{"key":"2026100617000934000_bjo-2026-330339v1.35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/09286586.2017.1399427","article-title":"The influence of oral statin medications on progression of glaucomatous visual field loss: A propensity score analysis","volume":"25","author":"Whigham","year":"2018","journal-title":"Ophthalmic Epidemiol"},{"key":"2026100617000934000_bjo-2026-330339v1.36","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.66.15.7","article-title":"Association between statin use and glaucoma risk: a population-based study","volume":"66","author":"Pan","year":"2025","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2026100617000934000_bjo-2026-330339v1.37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00417-024-06620-9","article-title":"Associations of different types of statins with the risk of open-angle glaucoma: a systematic review and network meta-analysis","volume":"263","author":"Pan","year":"2025","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2026100617000934000_bjo-2026-330339v1.38","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ogla.2024.07.008","article-title":"Associations between statin use and glaucoma in the All of Us Research Program","volume":"7","author":"Lee","year":"2024","journal-title":"Ophthalmol Glaucoma"},{"key":"2026100617000934000_bjo-2026-330339v1.39","doi-asserted-by":"publisher","DOI":"10.1038\/89058"},{"key":"2026100617000934000_bjo-2026-330339v1.40","doi-asserted-by":"publisher","DOI":"10.1038\/82219"},{"key":"2026100617000934000_bjo-2026-330339v1.41","doi-asserted-by":"publisher","DOI":"10.1038\/nri1839"},{"key":"2026100617000934000_bjo-2026-330339v1.42","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.117.7.917"},{"key":"2026100617000934000_bjo-2026-330339v1.43","doi-asserted-by":"publisher","DOI":"10.1038\/79510"},{"key":"2026100617000934000_bjo-2026-330339v1.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceca.2004.02.011"},{"key":"2026100617000934000_bjo-2026-330339v1.45","doi-asserted-by":"publisher","DOI":"10.5551\/jat.9.178"},{"key":"2026100617000934000_bjo-2026-330339v1.46","first-page":"210","article-title":"Effects of atorvastatin on porcine aqueous humour outflow and trabecular meshwork cells","volume":"15","author":"Cong","year":"2018","journal-title":"Exp Ther Med"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjo-2026-330339","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:21Z","timestamp":1791331221000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjo-2026-330339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":46,"alternative-id":["10.1136\/bjo-2026-330339"],"URL":"https:\/\/doi.org\/10.1136\/bjo-2026-330339","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]}}}